IRBESARTAN 150 MG TABLET

IRBESARTAN
$0.1103per EA

Strength

150 mg/1

NDC

62332004290

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IRBESARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA091236

On Market Since

7/1/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price History

1W

0.0%

1M

-1.2%

3M

-3.9%

6M

-4.1%

1Y

-10.7%

3Y

-24.4%

5Y

-53.4%

All

-43.3%